Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.46 - $0.77 $54,014 - $90,415
-117,423 Reduced 7.21%
1,510,654 $1.06 Million
Q4 2022

Feb 14, 2023

SELL
$0.51 - $17.1 $296,205 - $9.93 Million
-580,795 Reduced 26.29%
1,628,077 $1.16 Million
Q3 2022

Nov 14, 2022

SELL
$1.01 - $17.0 $239,288 - $4.03 Million
-236,919 Reduced 9.69%
2,208,872 $3.36 Million
Q2 2022

Aug 15, 2022

SELL
$0.54 - $1.41 $154,475 - $403,351
-286,065 Reduced 10.47%
2,445,791 $2.43 Million
Q1 2022

May 16, 2022

SELL
$1.4 - $5.15 $1.25 Million - $4.61 Million
-895,693 Reduced 24.69%
2,731,856 $3.93 Million
Q4 2021

Feb 14, 2022

SELL
$4.27 - $6.97 $527,652 - $861,296
-123,572 Reduced 3.29%
3,627,549 $18.9 Million
Q3 2021

Nov 15, 2021

SELL
$5.31 - $8.25 $132,750 - $206,250
-25,000 Reduced 0.66%
3,751,121 $21.9 Million
Q1 2021

May 17, 2021

SELL
$7.99 - $15.0 $239,843 - $450,270
-30,018 Reduced 0.79%
3,776,121 $31.4 Million
Q4 2020

Feb 16, 2021

SELL
$7.04 - $11.7 $2.01 Million - $3.34 Million
-285,610 Reduced 6.98%
3,806,139 $28.9 Million
Q3 2020

Nov 16, 2020

BUY
$9.98 - $18.04 $227,613 - $411,438
22,807 Added 0.56%
4,091,749 $43.6 Million
Q2 2020

Aug 14, 2020

SELL
$7.49 - $15.16 $249,754 - $505,510
-33,345 Reduced 0.81%
4,068,942 $61.7 Million
Q1 2020

May 15, 2020

SELL
$4.62 - $18.74 $512,196 - $2.08 Million
-110,865 Reduced 2.63%
4,102,287 $34.2 Million
Q4 2019

Feb 14, 2020

SELL
$14.6 - $18.13 $1.97 Million - $2.45 Million
-134,988 Reduced 3.1%
4,213,152 $71.2 Million
Q3 2019

Nov 14, 2019

SELL
$16.62 - $23.92 $136,666 - $196,694
-8,223 Reduced 0.19%
4,348,140 $80.7 Million
Q2 2019

Aug 14, 2019

BUY
$17.79 - $22.88 $120,972 - $155,584
6,800 Added 0.16%
4,356,363 $99.7 Million
Q1 2019

May 15, 2019

BUY
$11.76 - $22.15 $1.78 Million - $3.36 Million
151,541 Added 3.61%
4,349,563 $91.4 Million
Q4 2018

Feb 14, 2019

BUY
$10.42 - $21.94 $113,338 - $238,641
10,877 Added 0.26%
4,198,022 $48.3 Million
Q3 2018

Nov 14, 2018

SELL
$20.4 - $24.6 $1.77 Million - $2.14 Million
-86,935 Reduced 2.03%
4,187,145 $96.1 Million
Q2 2018

Aug 14, 2018

BUY
$19.02 - $24.95 $81.3 Million - $107 Million
4,274,080 New
4,274,080 $95.3 Million

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Oracle Investment Management Inc Portfolio

Follow Oracle Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oracle Investment Management Inc with notifications on news.